Acesion Pharma
Acesion Pharma is a Danish biotech company pioneering SK ion channel inhibition to develop safe and efficacious drugs for atrial fibrillation.
Last updated September 1, 2026
Overview
Acesion Pharma is a Danish biotech company founded in 2011 and based in Copenhagen. It is pioneering the development of safe and efficacious antiarrhythmic drugs for the treatment of atrial fibrillation, the most common type of cardiac arrhythmia. The company's technology is based on research initiated in 2008 at University of Copenhagen and chemistry insights from Neurosearch. Acesion Pharma is a leading company within development of SK ion channel inhibitors for severe heart diseases.
History
Acesion Pharma was founded in 2011 and is based in Copenhagen. Its technology is based on research initiated in 2008 at University of Copenhagen and chemistry insights from the company Neurosearch. The company is pioneering the development of safe and efficacious antiarrhythmic drugs for the treatment of atrial fibrillation, the most common type of cardiac arrhythmia. It is a leading company within development of SK ion channel inhibitors for severe heart diseases.
Sources
Cite this profile: Cite the canonical profile. /brand-wiki/acesion-pharma-denmark · Editorial policy · How profiles are compiled